Daily non-political popular news in brief.

Study suggests test for p53 is needed to prescreen patients for blood cancer drugs

Researchers have determined a way to prescreen cancer patients to see if they are suitable candidates for proteasome inhibitors, a promising class of anti-cancer drugs. They propose to test for p53, a well-known tumor-suppressor protein that is broken down by cellular machinery called proteasomes.

Read more »

Keywords: study, suggests, test, p53, needed, prescreen, patients, blood, cancer, drugs, suggest, patient, drug

« Previous | Next »

Similar news on "Study suggests test for p53 is needed to prescreen patients for blood cancer drugs":

1. Preventing graft-versus-host disease disease after bone marrow transplant -- without toxicity
   12-11-2006 · EurekAlert!
   Most patients undergoing bone-marrow transplant must receive powerful chemotherapy drugs to suppress their immune system and prevent their bodies from rejecting the donated cells. New research shows that this chemotherapy increases the risk for graft-versus-host disease -- but also suggests that this risk can be reduced by replacing a natural antibiotic that's depleted when patients undergo chemotherapy. A multicenter study led by Children's Hospital Boston and the Dana-Farber Cancer Institute is about to test this idea.
   Similar news · Read more »
   
2. Mouse tests predict drug response in relapsing pancreatic cancer patients
   10-11-2006 · EurekAlert!
   By slicing up bits of patient tumors and grafting them into mice, Johns Hopkins Kimmel Cancer Center specialists have figured out how to accurately "test drive" chemotherapy drugs to learn in advance which drug treatments offer each individual pancreatic cancer patient the best therapeutic journey.
   Similar news · Read more »
   
3. Study produces conflicting findings on the use of anti-anemia drug in cancer patients
   04-16-2007 · EurekAlert!
   Results from a phase III drug trial indicate that an anti-anemia drug did not significantly decrease the need for blood transfusions in patients not on chemotherapy, and decreased overall patient survival when compared to placebo, according to researchers from the UCLA Medical Center at the 2007 Annual Meeting of the American Association for Cancer Research.
   Similar news · Read more »
   
4. Penn's Abramson Cancer Center part of major phase III study for myeloma
   11-21-2007 · EurekAlert!
   Researchers from the UPenn's Abramson Cancer Center announced today that findings from two international clinical trials show unprecedented survival for patients with myeloma, a cancer the blood-making cells of bone marrow. Findings show that with the oral drug lenalidomide, in combination with dexamethasone, patients significantly improved by all measures where previous treatments had failed -- including a median survival of nearly three years -- the longest median survival known for this difficult to treat patient group.
   Similar news · Read more »
   
5. Mouse Tests Predict Drug Response In Relapsing Pancreatic Cancer Patients
   10-12-2006 · ScienceDaily
   By slicing up bits of patient tumors and grafting them into mice, Johns Hopkins Kimmel Cancer Center specialists have figured out how to accurately 'test drive' chemotherapy drugs to learn in advance which drug treatments offer each individual pancreatic cancer patient the best therapeutic journey.
   Similar news · Read more »
   
6. Preventing graft-vs.-host disease after bone marrow transplant -- without toxicity
   12-11-2006 · EurekAlert!
   Most patients undergoing bone-marrow transplant must receive powerful chemotherapy drugs to suppress their immune system and prevent their bodies from rejecting the donated cells. New research shows that this chemotherapy increases the risk for graft-versus-host disease -- but also suggests that this risk can be reduced by replacing a natural antibiotic that's depleted when patients undergo chemotherapy. A multicenter study led by Children's Hospital Boston and the Dana-Farber Cancer Institute is about to test this idea.
   Similar news · Read more »
   
7. Study suggests newer breast cancer drug may protect heart
   06-08-2007 · EurekAlert!
   By uncovering how one breast cancer drug protects the heart and another does not, Duke University Medical Center researchers believe they may have opened up a new way to screen drugs for possible heart-related side effects and to develop new drugs.
   Similar news · Read more »
   
8. St. Jude shows gene test not needed if cancer drug given in low doses
   06-19-2007 · EurekAlert!
   Investigators at St. Jude Children's Research Hospital have shown that when the cancer drug irinotecan is given in low doses for multiple days, it eliminates the need to delay treatment to perform costly genetic testing that determines if the patient is at risk for serious treatment side effects, such as neutropenia.
   Similar news · Read more »
   
9. Drug that chokes off tumor blood vessels offers new hope to lung cancer patients
   12-13-2006 · EurekAlert!
   Patients suffering from the most common type of lung cancer experienced a 20-percent improvement in overall survival in a national clinical trial of a drug that chokes off the blood vessels nourishing tumors, a multicenter study has found.
   Similar news · Read more »
   
10. Blood test may help signal tumor's remission, return in throat cancer patients
    06-01-2007 · EurekAlert!
    A blood test that detects proteins commonly released by a growing tumor could one day become a useful tool for monitoring the effectiveness of chemotherapy and radiation treatment in people with advanced throat cancer, according to a study published in the June 1, 2007, issue of Clinical Cancer Research.
    Similar news · Read more »